These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17325214

  • 21. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L, Ojeda MI, de Mier C, Vay C, Famiglietti A, Gutkind G, Mollerach M.
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [Abstract] [Full Text] [Related]

  • 22. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
    Calatayud L, Ardanuy C, Cercenado E, Fenoll A, Bouza E, Pallares R, Martín R, Liñares J.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
    [Abstract] [Full Text] [Related]

  • 23. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
    Brown SD, Farrell DJ, Morrissey I.
    J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
    [Abstract] [Full Text] [Related]

  • 24. Recombination rates of Streptococcus pneumoniae isolates with both erm(B) and mef(A) genes.
    Lee JY, Song JH, Ko KS.
    FEMS Microbiol Lett; 2010 Aug 01; 309(2):163-9. PubMed ID: 20618866
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.
    Reinert RR, Filimonova OY, Al-Lahham A, Grudinina SA, Ilina EN, Weigel LM, Sidorenko SV.
    Antimicrob Agents Chemother; 2008 Jun 01; 52(6):2260-2. PubMed ID: 18378707
    [Abstract] [Full Text] [Related]

  • 26. Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
    Xu X, Cai L, Xiao M, Kong F, Oftadeh S, Zhou F, Gilbert GL.
    Antimicrob Agents Chemother; 2010 Mar 01; 54(3):1152-9. PubMed ID: 20065057
    [Abstract] [Full Text] [Related]

  • 27. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy.
    Monaco M, Camilli R, D'Ambrosio F, Del Grosso M, Pantosti A.
    J Antimicrob Chemother; 2005 Feb 01; 55(2):256-9. PubMed ID: 15649990
    [Abstract] [Full Text] [Related]

  • 28. Characterisation of macrolide-non-susceptible Streptococcus pneumoniae colonising children attending day-care centres in Athens, Greece during 2000 and 2003.
    Souli M, Volonakis K, Kapaskelis A, Galani I, Grammelis V, Vorou R, Tsivra M, Chryssouli Z, Katsala D, Giamarellou H.
    Clin Microbiol Infect; 2007 Jan 01; 13(1):70-7. PubMed ID: 17184290
    [Abstract] [Full Text] [Related]

  • 29. Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?
    Lambertsen L, Ekelund K, Hansen DS, Kaltoft M, Christensen JJ, Hammerum AM.
    Scand J Infect Dis; 2008 Jan 01; 40(6-7):584-7. PubMed ID: 18584554
    [Abstract] [Full Text] [Related]

  • 30. Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004.
    Zhanel GG, Wang X, Nichol K, Nikulin A, Wierzbowski AK, Mulvey M, Hoban DJ.
    Int J Antimicrob Agents; 2006 Nov 01; 28(5):465-71. PubMed ID: 17049211
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.
    Fitoussi F, Doit C, Geslin P, Brahimi N, Bingen E.
    Antimicrob Agents Chemother; 2001 Feb 01; 45(2):636-8. PubMed ID: 11158772
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.
    Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, Schmitz FJ.
    J Clin Microbiol; 2005 Mar 01; 43(3):1294-300. PubMed ID: 15750098
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
    Farrell DJ, File TM, Jenkins SG.
    J Clin Microbiol; 2007 Feb 01; 45(2):290-3. PubMed ID: 17093012
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
    Noguchi N, Tano J, Nasu Y, Koyama M, Narui K, Kamishima H, Saito T, Tsuyuki K, Sasatsu M.
    Int J Antimicrob Agents; 2007 Jan 01; 29(1):26-33. PubMed ID: 17189091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.